Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.62 |
| ▸ | HPGD | P15428 | 3/20 | 0.62 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | RXRA | P19793 | 4/20 | 0.62 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.62 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.62 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.62 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | RXRB | P28702 | 3/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29556736 | 1.00 | MRGPRX4 (0.62) | MRGPRX4HPGDNPC1RAB9ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL10857748 | 0.98 | MRGPRX4 (0.61) | MRGPRX4HPGDNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4280782 | 0.92 | MRGPRX4 (0.74) | MRGPRX4HPGDNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3944668 | 0.92 | MRGPRX4 (0.59) | MRGPRX4HPGDNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL242563 | 0.91 | MRGPRX4 (0.77) | MRGPRX4HPGDNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL29375753 | 0.91 | SMPD1 (0.75) | MRGPRX4HPGDNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1029034 | 0.91 | SMPD1 (0.75) | MRGPRX4HPGDNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL7863787 | 0.90 | MRGPRX4 (0.56) | MRGPRX4HPGDNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL9197479 | 0.89 | MEN1 (0.56) | MRGPRX4HPGDNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL11271923 | 0.89 | SMPD1 (0.73) | MRGPRX4HPGDNPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678637-A1 | NOVEL FLAVONE DERIVATIVE AND USE THEREOF IN ALLEVIATING PULMONARY FIBROSIS | A-chembio Co., Ltd (KR) | 2026-01-14 | — | — | EP | disclosed |
| US-20250120944-A1 | ANTIBACTERIAL COMPOSITION | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-04-17 | — | — | US | disclosed |
| US-20240336588-A1 | COMPOSITIONS AND METHODS FOR ANTIOXIDANT AND ANTI-INFLAMMATORY THERAPEUTICS | AVANTI BIOSCIENCES, INC. | 2024-10-10 | — | — | US | disclosed |
| WO-2024186175-A1 | NOVEL FLAVONE DERIVATIVE AND USE THEREOF IN ALLEVIATING PULMONARY FIBROSIS | 주식회사 에이켐바이오 | 2024-09-12 | — | — | WO | disclosed |
| US-20240300913-A1 | FLAVONE DERIVATIVE AND USE THEREOF FOR IMPROVING PULMONARY FIBROSIS | A-CHEMBIO CO., LTD (KR) | 2024-09-12 | — | — | US | disclosed |
| EP-4410774-A1 | ANTIBACTERIAL COMPOSITION | Seoul National University R&DB Foundation (KR) | 2024-08-07 | — | — | EP | disclosed |
| EP-4370113-A1 | COMPOSITIONS AND METHODS FOR ANTIOXIDANT AND ANTI-INFLAMMATORY THERAPEUTICS | Avanti Biosciences Inc. (US) | 2024-05-22 | — | — | EP | disclosed |
| WO-2023048337-A1 | ANTIBACTERIAL COMPOSITION | 서울대학교산학협력단 | 2023-03-30 | — | — | WO | disclosed |
| WO-2023288020-A1 | COMPOSITIONS AND METHODS FOR ANTIOXIDANT AND ANTI-INFLAMMATORY THERAPEUTICS | AVANTI BIOSCIENCES INC. (US) | 2023-01-19 | — | — | WO | disclosed |
| WO-2023288020-A1 | COMPOSITIONS AND METHODS FOR ANTIOXIDANT AND ANTI-INFLAMMATORY THERAPEUTICS | AVANTI BIOSCIENCES INC. (US) | 2023-01-19 | — | — | WO | disclosed |
| US-4501912-A | AMINO-2-HYDROXYROPYLBENZOATE COMPOUND OR SALT WITH LONG DURATION IN OCULAR FLUID; RAPID METABOLISM | AMERICAN HOSPITAL SUPPLY CORPORATION (US) | 1985-02-26 | — | — | US | disclosed |
| EP-0093765-A4 | 2-HYDROXYPROPYLAMINE ARYL ESTER DERIVATIVES. | AMERICAN HOSPITAL SUPPLY CORP (US) | 1984-04-27 | — | — | EP | disclosed |
| EP-0081580-A4 | COMPOSITIONS FOR TREATING GLAUCOMA. | AMERICAN HOSPITAL SUPPLY CORP (US) | 1983-12-01 | — | — | EP | disclosed |
| EP-0093765-A1 | 2-HYDROXYPROPYLAMINE ARYL ESTER DERIVATIVES. | AMERICAN HOSPITAL SUPPLY CORP (US) | 1983-11-16 | — | — | EP | disclosed |
| US-4402974-A | WITH CARBOXY, OXY, CARBO-AMINE | AMERICAN HOSPITAL SUPPLY CORPORATION (US) | 1983-09-06 | — | — | US | disclosed |
| EP-0081580-A1 | COMPOSITIONS FOR TREATING GLAUCOMA. | AMERICAN HOSPITAL SUPPLY CORP (US) | 1983-06-22 | — | — | EP | disclosed |
| WO-1983001770-A1 | 2-HYDROXYPROPYLAMINE ARYL ESTER DERIVATIVES | AMERICAN HOSPITAL SUPPLY CORP (US) | 1983-05-26 | — | — | WO | disclosed |
| WO-1983000043-A1 | COMPOSITIONS FOR TREATING GLAUCOMA | AMERICAN HOSPITAL SUPPLY CORP (US) | 1983-01-06 | — | — | WO | disclosed |
| US-4239903-A | ANTISPASMODIC AGENTS | DAIICHI SEIYAKU CO., LTD. (JP) | 1980-12-16 | — | — | US | disclosed |
| US-4118507-A | Benzodioxincarboxamide lipogenesis inhibitors | SHELL OIL COMPANY (US) | 1978-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250120944-A1 | ANTIBACTERIAL COMPOSITION | SQSTM1, BECN1, ATG7 | MRGPRX4 2939/4885HPGD 3714/4885NPC1 553/4885 |
| US-20240336588-A1 | COMPOSITIONS AND METHODS FOR ANTIOXIDANT AND ANTI-INFLAMMATORY THERAPEUTICS | MPO, GPX4, GPX1 | MRGPRX4 3223/4885HPGD 147/4885NPC1 2007/4885 |
| US-20240300913-A1 | FLAVONE DERIVATIVE AND USE THEREOF FOR IMPROVING PULMONARY FIBROSIS | HGF, FN1, SMAD2 | MRGPRX4 3065/4885HPGD 2542/4885NPC1 4419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.